The term TERF1P2 Inhibitors represents a specialized class of chemical compounds designed to modulate the activity of TERF1P2, a molecular target currently under scientific investigation. These inhibitors are meticulously crafted through principles rooted in medicinal chemistry, with a primary focus on selectively interfering with the normal functions of TERF1P2 within cellular processes. The structural features of TERF1P2 Inhibitors undergo a rigorous optimization process, often involving computational modeling and structure-activity relationship studies, to refine their molecular configurations for precise binding to the target.
The significance of TERF1P2 Inhibitors lies in their potential to disrupt the biochemical activities associated with TERF1P2, a molecular entity believed to play a role in various biological pathways. Researchers in this field delve into the three-dimensional structure of TERF1P2 and its binding interactions with inhibitors, aiming to unravel the intricate molecular mechanisms underlying inhibition. The study of TERF1P2 Inhibitors contributes to a broader understanding of cellular processes, offering insights into the roles played by TERF1P2 in diverse biological pathways and expanding our knowledge of the regulatory networks governing cellular activities. This research not only advances our comprehension of the molecular intricacies surrounding TERF1P2 but also contributes to the broader scientific understanding of molecular targets and their involvement in fundamental cellular functions.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus can inhibit mTOR, which is a key regulator of protein synthesis. This could indirectly lead to a reduction in the expression of various proteins, potentially including TERF1P2. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds to heat shock protein 90 (Hsp90) and can interfere with its function, possibly affecting the stability and function of client proteins and their expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to affect various signaling pathways and may modulate gene expression, potentially impacting proteins such as TERF1P2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which might reduce the activity of downstream signaling pathways involved in protein synthesis, possibly affecting TERF1P2 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of the MAP kinase pathway, which could lead to altered gene expression profiles, potentially reducing the expression of certain proteins. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which may influence transcription factors and gene expression, potentially impacting protein levels, including TERF1P2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor that could alter the expression of genes regulated by this pathway, potentially including TERF1P2. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG is an Hsp90 inhibitor similar to Geldanamycin, which might affect the expression and stability of a range of proteins. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin interferes with protein synthesis at the level of peptide elongation, which could lead to reduced expression of many proteins. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Nutlin-3 disrupts the interaction between p53 and MDM2, potentially enhancing p53 activity and affecting the expression of p53-regulated genes. | ||||||